Paraoxonase-Gene Polymorphisms Associated with Coronary Heart Disease: Support for the Oxidative Damage Hypothesis?
- 1 January 1998
- journal article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 62 (1) , 20-24
- https://doi.org/10.1086/301691
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The role of oxidized lipoproteins in atherogenesisPublished by Elsevier ,1999
- Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosisCurrent Opinion in Lipidology, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM StudyAtherosclerosis, 1996
- The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.Journal of Clinical Investigation, 1996
- Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrationsBiochemical Journal, 1994
- Oxidants, antioxidants, and the degenerative diseases of aging.Proceedings of the National Academy of Sciences, 1993
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequenceBiochemistry, 1991